Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma
ALAMEDA, Calif.–(BUSINESS WIRE)–Jan. 14, 2019– Exelixis, Inc. (NASDAQ:EXEL) today announced that the U.S. Food and Drug Administration (FDA) approved Cabometyx
What to Watch: Beauty Trends Driving Products and Services in 2019
Encouraged by social media trends, beauty consumers are seeking new services, which is driving innovation across categories in 2019. Below,
Gene-editing tool CRISPR/Cas9 shown to limit impact of certain parasitic diseases
For the first time, researchers at the George Washington University (GW), together with colleagues at institutes in Thailand, Australia, the
Gene therapies only work for some people – so how do we fix this?
Growing up in Devon in the 1980s, brothers James and Matt (names have been changed) had to be careful with
Doctors a rafts man 15 cans of beer and save his life
With 15 cans of beer a medic in Vietnam have healed a man of severe alcohol intoxication. The 48-Year-old had
I Watched Fortnite Porn to Figure Out Why People Are So Into It
Pornhub recently released their report on the most popular porn searches of 2018, and one of the more surprising insights
A woman receives a donor lung and is suffering from the peanut Allergy of the donor
A donor lung was the only salvation for a 53-year-old American. The woman had developed due to a metabolic disorder,
The metabolic syndrome the body needs more Vitamin C
Researchers at the Oregon State University are of the opinion that a higher intake of Vitamin C for people with